Acknowledgements The authors would like to thank every researcher that contributed to the understanding of the close relationship between the IGF-1 deficiency and the Metabolic Syndrome establishment
Newer medications are exploring combinations of hormone-based injectables, like glucagon-like peptide-1 agonists, with other agents to improve results and reduce side effects
Studies exploring tendon healing, muscle injury models, and angiogenesis pathways have contributed to a growing body of literature, but this research has not progressed to human clinical trials, and BPC-157 is not approved by the FDA for any human or veterinary use
Both hGH and its C-terminal fragment reduce body weight gain, increase fat oxidation, and stimulate lipolysis in obese mice, yet AOD9604 does not interact with the hGH receptor Unfortunately, the AOD-904 results in human clinical trials didnt show the same level of promise